219 related articles for article (PubMed ID: 26296528)
1. Effect of androgen deprivation therapy on arterial stiffness and serum lipid profile changes in patients with prostate cancer: a prospective study of initial 6-month follow-up.
Oka R; Utsumi T; Endo T; Yano M; Kamijima S; Kamiya N; Shirai K; Suzuki H
Int J Clin Oncol; 2016 Apr; 21(2):389-396. PubMed ID: 26296528
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the lipid profile and atherogenic risk during androgen deprivation therapy in prostate cancer patients.
Salvador C; Planas J; Agreda F; Placer J; Trilla E; Lopez MA; Morote J
Urol Int; 2013; 90(1):41-4. PubMed ID: 23235105
[TBL] [Abstract][Full Text] [Related]
3. Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study.
Smith MR; Malkowicz SB; Chu F; Forrest J; Sieber P; Barnette KG; Rodriquez D; Steiner MS
J Clin Oncol; 2008 Apr; 26(11):1824-9. PubMed ID: 18398147
[TBL] [Abstract][Full Text] [Related]
4. Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control.
Ziaran S; Goncalves FM; Breza J
World J Urol; 2013 Apr; 31(2):289-92. PubMed ID: 22898989
[TBL] [Abstract][Full Text] [Related]
5. Negative associations between arterial stiffness parameter evaluated by cardio-ankle vascular index and serum low-density lipoprotein cholesterol concentration in early-stage atherosclerosis.
Homma S; Kato K; Hayashi J; Yamamoto M
Angiology; 2015 Feb; 66(2):143-9. PubMed ID: 24402322
[TBL] [Abstract][Full Text] [Related]
6. Bezafibrate Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Hypertriglyceridemic Patients with Type 2 Diabetes Mellitus.
Yamaguchi T; Shirai K; Nagayama D; Nakamura S; Oka R; Tanaka S; Watanabe Y; Imamura H; Sato Y; Kawana H; Ohira M; Saiki A; Shimizu N; Tatsuno I
J Atheroscler Thromb; 2019 Jul; 26(7):659-669. PubMed ID: 30584220
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy.
Braga-Basaria M; Muller DC; Carducci MA; Dobs AS; Basaria S
Int J Impot Res; 2006; 18(5):494-8. PubMed ID: 16617314
[TBL] [Abstract][Full Text] [Related]
8. Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma.
Albuquerque CP; Freitas FR; Martinelli AEM; Lima JH; Coelho RF; Serrano CV; Nahas WC; Kalil Filho R; Maranhão RC
Lipids Health Dis; 2020 Jun; 19(1):133. PubMed ID: 32522195
[TBL] [Abstract][Full Text] [Related]
9. Fasting blood glucose and lipid profile alterations following twelve-month androgen deprivation therapy in men with prostate cancer.
Sağlam HS; Köse O; Kumsar S; Budak S; Adsan O
ScientificWorldJournal; 2012; 2012():696329. PubMed ID: 23125556
[TBL] [Abstract][Full Text] [Related]
10. Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction.
Deguchi I; Horiuchi Y; Hayashi T; Sehara Y; Kato Y; Ohe Y; Fukuoka T; Maruyama H; Sano H; Nagamine Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2007-2011. PubMed ID: 25066602
[TBL] [Abstract][Full Text] [Related]
11. Relationship between cardio-ankle vascular index and plasma lipids in hypertension subjects.
Wang H; Liu J; Zhao H; Zhao X; Li L; Shi H; Zhan S; Liu J
J Hum Hypertens; 2015 Feb; 29(2):105-8. PubMed ID: 24831100
[TBL] [Abstract][Full Text] [Related]
12. Androgen deprivation therapy reversibly increases endothelium-dependent vasodilation in men with prostate cancer.
Nguyen PL; Jarolim P; Basaria S; Zuflacht JP; Milian J; Kadivar S; Graham PL; Hyatt A; Kantoff PW; Beckman JA
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25896892
[TBL] [Abstract][Full Text] [Related]
13. The effects of plant stanol ester consumption on arterial stiffness and endothelial function in adults: a randomised controlled clinical trial.
Gylling H; Halonen J; Lindholm H; Konttinen J; Simonen P; Nissinen MJ; Savolainen A; Talvi A; Hallikainen M
BMC Cardiovasc Disord; 2013 Jul; 13():50. PubMed ID: 23841572
[TBL] [Abstract][Full Text] [Related]
14. Effect of ezetimibe monotherapy on lipid metabolism and arterial stiffness assessed by cardio-ankle vascular index in type 2 diabetic patients.
Miyashita Y; Endo K; Saiki A; Ban N; Nagumo A; Yamaguchi T; Kawana H; Nagayama D; Ohira M; Oyama T; Shirai K
J Atheroscler Thromb; 2010 Oct; 17(10):1070-6. PubMed ID: 20644331
[TBL] [Abstract][Full Text] [Related]
15. Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer.
Harrington JM; Schwenke DC; Epstein DR; Bailey DE
Oncol Nurs Forum; 2014 Jan; 41(1):21-9. PubMed ID: 24368236
[TBL] [Abstract][Full Text] [Related]
16. Lipid Status During Combined Treatment in Prostate Cancer Patients.
Wolny-Rokicka E; Tukiendorf A; Wydmański J; Ostrowska M; Zembroń-Łacny A
Am J Mens Health; 2019; 13(5):1557988319876488. PubMed ID: 31559896
[TBL] [Abstract][Full Text] [Related]
17. Cardio-ankle vascular index value in dyslipidemia patients affected by cardiovascular risk factors.
Zhao X; Bo L; Zhao H; Li L; Zhou Y; Wang H
Clin Exp Hypertens; 2018; 40(4):312-317. PubMed ID: 29048932
[TBL] [Abstract][Full Text] [Related]
18. Association of serum lipids with arterial stiffness in a population-based study in Beijing.
Wang F; Ye P; Luo L; Xiao W; Qi L; Bian S; Wu H; Sheng L; Xiao T; Xu R
Eur J Clin Invest; 2011 Sep; 41(9):929-36. PubMed ID: 21314825
[TBL] [Abstract][Full Text] [Related]
19. Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness.
Takaki A; Ogawa H; Wakeyama T; Iwami T; Kimura M; Hadano Y; Matsuda S; Miyazaki Y; Hiratsuka A; Matsuzaki M
Hypertens Res; 2008 Jul; 31(7):1347-55. PubMed ID: 18957805
[TBL] [Abstract][Full Text] [Related]
20. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
Fizazi K; Faivre L; Lesaunier F; Delva R; Gravis G; Rolland F; Priou F; Ferrero JM; Houede N; Mourey L; Theodore C; Krakowski I; Berdah JF; Baciuchka M; Laguerre B; Fléchon A; Ravaud A; Cojean-Zelek I; Oudard S; Labourey JL; Chinet-Charrot P; Legouffe E; Lagrange JL; Linassier C; Deplanque G; Beuzeboc P; Davin JL; Martin AL; Habibian M; Laplanche A; Culine S
Lancet Oncol; 2015 Jul; 16(7):787-94. PubMed ID: 26028518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
